Summary & Overview
HCPCS J2002: Injection, Lidocaine HCl in 5% Dextrose, 1 mg
HCPCS Level II code J2002 designates an injectable preparation of lidocaine hydrochloride in 5% dextrose at a 1 mg unit. Nationally, codes for injectable local anesthetics are critical for billing medication administration in outpatient and procedural settings, affecting hospital outpatient departments, ambulatory surgical centers, and physician offices that administer periprocedural or regional anesthesia. Coverage and reimbursement for such drug codes influence facility charge capture and payer payment policies.
Key payers considered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical meaning and common sites of service, plus national benchmarking context where available. The publication outlines typical billing uses, payer coverage considerations, and related policy and billing implications for injectable medications.
This summary provides clinicians, billing professionals, and policy analysts with the clinical context necessary to link treatment indications to billing workflows, an outline of which major payers are included in comparative discussions, and what to expect in sections covering benchmarks, policy updates, and clinical application. Data not provided in the input (such as associated taxonomies, ICD-10 pairing guidance, and specific reimbursement figures) is noted as unavailable in subsequent sections.
Billing Code Overview
HCPCS Level II code J2002 describes an injection of lidocaine hydrochloride in 5% dextrose, 1 mg. This code represents a single-dose injectable medication formulation of lidocaine combined with a dextrose carrier.
Service Type: Medication administration / injectable local anesthetic preparation
Typical Site of Service: Outpatient clinic, ambulatory surgery center, hospital outpatient department, or other infusion/medication administration settings
Clinical & Coding Specifications
Clinical Context
A typical patient is a 45-year-old male presenting to an outpatient infusion suite for an intralesional or regional anesthetic administration prior to a minor procedure or diagnostic intervention. The clinician prepares J2002 (Injection, lidocaine hcl in 5% dextrose, 1 mg) for local infiltration or for addition to an infusion bag to provide regional anesthesia or procedural pain control. The workflow: pre-procedure assessment including allergies and medication review; informed consent for local anesthetic; medication preparation and dose calculation by nursing/pharmacy staff; administration by the performing provider (e.g., anesthesiologist, pain medicine physician, emergency medicine physician, or proceduralist) using aseptic technique; monitoring of vital signs and neurovascular status during and after administration; documentation of medication name, dose, route, site, lot number, and any immediate reaction; discharge when recovery criteria are met.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typical for the service due to complexity or complication. |
23 | Unusual anesthesia | Use when general anesthesia is required for a procedure normally done with local/monitored anesthesia.